Editorial Expression of Concern: p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells

Saved in:

Bibliographic Details
Published in:	Oncogene Vol. 43; no. 40; p. 3018
Main Authors:	Hideshima, Teru, Podar, Klaus, Chauhan, Dharminder, Ishitsuka, Kenji, Mitsiades, Constantine, Tai, Yu-Tzu, Hamasaki, Makoto, Raje, Noopur, Hideshima, Hiromasa, Schreiner, George, Nguyen, Aaron N., Navas, Tony, Munshi, Nikhil C., Richardson, Paul G., Higgins, Linda S., Anderson, Kenneth C.
Format:	Journal Article
Language:	English
Published:	London Nature Publishing Group UK 27-09-2024 Nature Publishing Group
Subjects:	Antineoplastic Agents - pharmacology Apoptosis Boronic Acids - pharmacology Bortezomib - pharmacology Cell Biology Cell Line, Tumor Editorial Expression of Concern Human Genetics Humans Internal Medicine Medicine Medicine & Public Health Multiple Myeloma - drug therapy Multiple Myeloma - genetics Multiple Myeloma - pathology Oncology p38 Mitogen-Activated Protein Kinases - metabolism Pyrazines - pharmacology
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	SourceType-Scholarly Journals-1 content type line 23 ObjectType-Editorial-2 ObjectType-Undefined-3 ObjectType-Commentary-1
ISSN:	0950-9232 1476-5594 1476-5594
DOI:	10.1038/s41388-024-03147-5